Literature DB >> 20627923

Population-based study of lung function and incidence of heart failure hospitalisations.

Gunnar Engström1, Olle Melander, Bo Hedblad.   

Abstract

BACKGROUND: Reduced forced expiratory volume (FEV(1)) and forced vital capacity (FVC) are risk factors for myocardial infarction (MI) and stroke. However, the relationship with incidence of heart failure (HF) is incompletely known. This population-based study explored whether reduced FEV(1) or FVC is associated with the incidence of hospitalisation for HF.
METHODS: 20 998 men (mean age 43 years) with no history of MI or stroke were examined with spirometry in 1974-84. The incidence of hospitalisation due to HF was studied over a mean follow-up of 23 years in relation to age- and height-adjusted FEV(1) and FVC.
RESULTS: 725 incident HF hospitalisations occurred during the follow-up period, 503 of them without a previous or concurrent diagnosis of MI. In non-smokers the risk factor-adjusted hazard ratio (HR) for HF hospitalisation was 1.25 (95% CI 1.11 to 1.40) and 1.26 (95% CI 1.13 to 1.42), respectively, per 1SD lower FEV(1) and FVC. The corresponding risk factor-adjusted HRs in smokers were 1.32 (95% CI 1.21 to 1.45) and 1.22 (95% CI 1.11 to 1.33), respectively, for FEV(1) and FVC. This relationship was consistent in men with and without hypertension, in men above and below the median age of 44 years and for HF events without previous or concurrent MI. Exclusion of cases with a diagnosis of chronic obstructive pulmonary disease during the follow-up period did not substantially change the results.
CONCLUSION: In this long-term population-based study of men, moderately reduced FEV(1) and FVC were associated with an increased incidence of hospitalisations due to HF.

Entities:  

Mesh:

Year:  2010        PMID: 20627923     DOI: 10.1136/thx.2010.135392

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Sunil K Agarwal; Gerardo Heiss; R Graham Barr; Patricia P Chang; Laura R Loehr; Lloyd E Chambless; Eyal Shahar; Dalane W Kitzman; Wayne D Rosamond
Journal:  Eur J Heart Fail       Date:  2012-02-25       Impact factor: 15.534

3.  Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita
Journal:  Am J Kidney Dis       Date:  2017-07-26       Impact factor: 8.860

4.  Healthy Diets and Lung Health. Connecting the Dots.

Authors:  David R Jacobs; Ravi Kalhan
Journal:  Ann Am Thorac Soc       Date:  2016-05

5.  Rate of decline of forced vital capacity predicts future arterial hypertension: the Coronary Artery Risk Development in Young Adults Study.

Authors:  David R Jacobs; Hiroshi Yatsuya; Mary O Hearst; Bharat Thyagarajan; Ravi Kalhan; Sharon Rosenberg; Lewis J Smith; R Graham Barr; Daniel A Duprez
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

Review 6.  Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine.

Authors:  Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

7.  Long-term mortality in patients with chronic obstructive pulmonary disease following extracorporeal membrane oxygenation for cardiac assist after cardiovascular surgery.

Authors:  Klaus Distelmaier; Alexander Niessner; Dominik Haider; Irene M Lang; Gottfried Heinz; Gerald Maurer; Herbert Koinig; Barbara Steinlechner; Georg Goliasch
Journal:  Intensive Care Med       Date:  2013-04-24       Impact factor: 17.440

8.  Associations among lung function, arterial elasticity, and circulating endothelial and inflammation markers: the multiethnic study of atherosclerosis.

Authors:  Daniel A Duprez; Mary O Hearst; Pamela L Lutsey; David M Herrington; Pamela Ouyang; R Graham Barr; David A Bluemke; David McAllister; J Jeffrey Carr; David R Jacobs
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

9.  Declining Lung Function and Cardiovascular Risk: The ARIC Study.

Authors:  Odilson M Silvestre; Wilson Nadruz; Gabriela Querejeta Roca; Brian Claggett; Scott D Solomon; Maria C Mirabelli; Stephanie J London; Laura R Loehr; Amil M Shah
Journal:  J Am Coll Cardiol       Date:  2018-09-04       Impact factor: 24.094

Review 10.  Lung function and cardiovascular disease: A link.

Authors:  Sergio H R Ramalho; Amil M Shah
Journal:  Trends Cardiovasc Med       Date:  2020-01-03       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.